TABLE 3.
Summary of main features of ZIKV infection in MAb-treated CC strains and 129-Ifnar1 micea
| Mouse strain | Symptoms | Mortality (%) | Peak plasma viral load | Rate of decrease of plasma viral load | Systemic infection |
Intracerebral infection |
Viral replication in vitro (24–72 h) | ||
|---|---|---|---|---|---|---|---|---|---|
| Brain viral load | Brain pathology | Brain viral load | Brain pathology | ||||||
| CC001 | − | 0 | + | Moderate | + | − | + | ++ | Decreasing |
| CC005 | − | 0 | +++ | Fast | +++ | +++ | +++ | +++ | ND |
| CC071 | +++ | 78 | +++ | Moderate | +++ | ++ | +++ | ++++ | Increasing |
| 129-Ifnar | ++ | 12.50 | +++ | Fast | +++ | +++ | +++ | ++++ | ND |
−, absent; +, ++, +++, and ++++, present at increasing levels; ND, not done.